Cell Cycle/Checkpoint
Cell Cycle/Checkpoint(细胞周期/检查点)
Cell Cycle
Cells undergo a complex cycle of growth and division that is referred to as the cell cycle. The cell cycle consists of four phases, G1 (GAP 1), S (synthesis), G2 (GAP 2) and M (mitosis). DNA replication occurs during S phase. When cells stop dividing temporarily or indefinitely, they enter a quiescent state called G0. read more
- ATM/ATR(29)
- Aurora Kinase(58)
- Cdc42(4)
- Cdc7(3)
- Chk(14)
- c-Myc(27)
- CRM1(8)
- Cyclin-Dependent Kinases(77)
- E1 enzyme(1)
- G-quadruplex(12)
- Haspin(6)
- HMTase(1)
- Kinesin(27)
- Ksp(4)
- Microtubule/Tubulin(257)
- Mps1(15)
- Mitotic(7)
- RAD51(13)
- ROCK(74)
- Rho(13)
- PERK(11)
- PLK(43)
- PTEN(6)
- Wee1(9)
- PAK(25)
- Arp2/3 Complex(8)
- Dynamin(14)
- ECM & Adhesion Molecules(54)
- Cytoskeleton & Motor Proteins(65)
- Endomembrane System & Vesicular Trafficking(36)
- G1(51)
- Genotoxic Stress(23)
- G2/M(40)
- G2/S(17)
- Inositol Phosphates(67)
- Proteolysis(183)
- Cellular Chaperones(14)
- Cyclin G-associated Kinase (GAK)(1)
- MARK(3)
- NEKs(1)
Cell Cycle/Checkpoint 相关产品(1379)
- GC18353Prostaglandin A2CAS: 13345-50-1纯度: >98.00%
A naturally occurring prostaglandin with antiviral/antitumor activity
- GC18522Phosphatidylserines (sodium salt)CAS: 383908-63-2纯度: >95.00%
A mixture of phosphatidylserines isolated from soy
- GC185394-Hydroxyretinoic acid (4-HRA)CAS: 66592-72-1纯度: >98.00%
4-Hydroxyretinoic acid (4-HRA)是一种天然存在的，由全反式视黄酸（ATRA）经细胞色素P450酶代谢生成的主要代谢产物。
- GC18616MMP-8 Inhibitor ICAS: 236403-25-1纯度: >95.00% / >98.00%
MMP-8 Inhibitor I是一种强效的基质金属蛋白酶-8（MMP-8）抑制剂，但口服生物利用度较低。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18274 | Amiprofos-methyl | 36001-88-4 | - | |
An herbicide | ||||
| GC18275 | 1,2-Dihexadecyl-sn-glycero-3-PC | 36314-47-3 | - | |
A synthetic ether-linked phospholipid | ||||
| GC18278 | NU 6102 | 444722-95-6 | >99.50% | |
NU 6102是一种强效的CDK1和CDK2抑制剂，对CDK1/cyclin B和CDK2/cyclin A3的IC 50 值分别为9.5nM和5.4nM。 | ||||
| GC18315 | Calpain Inhibitor VI | 190274-53-4 | >95.00% | |
A calpain and cathepsin inhibitor | ||||
| GC18345 | Leptomycin A | 87081-36-5 | - | |
An inhibitor of nuclear transport | ||||
| GC18353 | Prostaglandin A2 | 13345-50-1 | >98.00% | |
A naturally occurring prostaglandin with antiviral/antitumor activity | ||||
| GC18359 | 4-Epianhydrochlortetracycline (hydrochloride) | 158018-53-2 | - | |
An inhibitor of MMP-9 | ||||
| GC18363 | Mca-DEVDAPK(Dnp)-OH | 189696-20-6 | - | |
A caspase-3 fluorogenic substrate | ||||
| GC18386 | Aloisine RP106 | 496864-15-4 | >98.00% | |
An inhibitor of Cdk1, Cdk5, and GSK3 | ||||
| GC18408 | BML-278 | 120533-76-8 | - | |
An activator of SIRT1, SIRT2, and SIRT3 | ||||
| GC18421 | Dabcyl-YVADAPV-EDANS | 161877-70-9 | - | |
A fluorogenic substrate for caspase-1 | ||||
| GC18437 | Alternariol monomethyl ether | 23452-05-3 | - | |
A mycotoxin | ||||
| GC18445 | N-Deacetylcolchicine | 3476-50-4 | - | |
An inhibitor of microtubule polymerization | ||||
| GC18449 | Cardanol monoene | 501-26-8 | - | |
An inhibitor of tyrosinase with anticancer properties | ||||
| GC18452 | 3,4-Dichloroisocoumarin | 51050-59-0 | >99.50% | |
A serine protease inhibitor | ||||
| GC18522 | Phosphatidylserines (sodium salt) | 383908-63-2 | >95.00% | |
A mixture of phosphatidylserines isolated from soy | ||||
| GC18539 | 4-Hydroxyretinoic acid (4-HRA) | 66592-72-1 | >98.00% | |
4-Hydroxyretinoic acid (4-HRA)是一种天然存在的，由全反式视黄酸（ATRA）经细胞色素P450酶代谢生成的主要代谢产物。 | ||||
| GC18565 | Suc-AAP-Abu-pNA | 108392-27-4 | - | |
A substrate for pancreatic elastase | ||||
| GC18578 | YK-3-237 | 1215281-19-8 | >99.50% | |
An inhibitor of tubulin polymerization and activator of SIRT1 | ||||
| GC18616 | MMP-8 Inhibitor I | 236403-25-1 | >95.00% / >98.00% | |
MMP-8 Inhibitor I是一种强效的基质金属蛋白酶-8（MMP-8）抑制剂，但口服生物利用度较低。 | ||||
| GC18666 | Debromohymenialdisine | 75593-17-8 | - | |
An inhibitor of Chk1 and Chk2 | ||||
| GC18693 | Fascaplysin (chloride) | 114719-57-2 | >95.00% | |
A selective Cdk4 inhibitor | ||||
| GC18699 | JCP174 | 126062-19-9 | - | |
An inhibitor of palmitoyl protein thioesterase-1 | ||||
| GC18720 | G-5555 | 1648863-90-4 | >99.00% | |
A PAK1 inhibitor | ||||